Home » Immucor Announces FDA Clearance of NEO
Immucor Announces FDA Clearance of NEO
April 30, 2010
Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood
transfusion industry, announced that its fourth generation automated instrument, NEO, has been cleared for marketing in the U.S. by the Food and Drug Administration
(FDA)
Breitbart
Breitbart
Upcoming Events
-
21Oct